Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipients

被引：0
|
作者：
Magalhaes-Silverman, M [1 ]
Carter, T [1 ]
Hohl, R [1 ]
Shamsuddin, H [1 ]
Gingrich, R [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
262
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [31] Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients
    Cho, J. C.
    Le, A. D.
    Locke, S. C.
    DRUGS OF TODAY, 2018, 54 (06) : 361 - 368
  • [32] Antifungal prophylaxis with itraconazole oral solution in patients undergoing allogeneic hematopoietic stem cell transplantation
    Skoetz, N
    Fuchs, M
    Holtick, U
    Scheid, C
    Diehl, V
    Waldschmidt, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S192 - S192
  • [33] Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
    Mori, Takehiko
    Kato, Jun
    Yamane, Akiko
    Sakurai, Masatoshi
    Kohashi, Sumiko
    Kikuchi, Taku
    Ono, Yukako
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (05) : 564 - 569
  • [34] Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
    Takehiko Mori
    Jun Kato
    Akiko Yamane
    Masatoshi Sakurai
    Sumiko Kohashi
    Taku Kikuchi
    Yukako Ono
    Shinichiro Okamoto
    International Journal of Hematology, 2012, 95 : 564 - 569
  • [35] Comparison of itraconacole, voriconazole and posaconazole as oral antifungal prophylaxis in paediatric patients following allogeneic stem cell transplantation
    Doering, M.
    Blume, O.
    Hartmann, U.
    Kimmig, A.
    Schwarze, C. -P.
    Handgretinger, R.
    Mueller, I.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S223 - S223
  • [36] Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation
    Marty, FM
    Lowry, CM
    Cutler, CS
    Campbell, BJ
    Fiumara, K
    Baden, LR
    Antin, JH
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (05) : 552 - 559
  • [37] Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation
    Amigues, I.
    Cohen, N.
    Chung, D.
    Seo, S. K.
    Plescia, C.
    Jakubowski, A.
    Barker, J.
    Papanicolaou, Genovefa A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : 46 - 52
  • [38] Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    S Trifilio
    R Ortiz
    G Pennick
    A Verma
    J Pi
    V Stosor
    T Zembower
    J Mehta
    Bone Marrow Transplantation, 2005, 35 : 509 - 513
  • [39] Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis
    Siwek, GT
    Dodgson, KJ
    de Magalhaes-Silverman, M
    Bartelt, LA
    Kilborn, SB
    Hoth, PL
    Diekema, DJ
    Pfaller, MA
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 584 - 587
  • [40] Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
    Trifilio, S
    Ortiz, R
    Pennick, G
    Verma, A
    Pi, J
    Stosor, V
    Zembower, T
    Mehta, J
    BONE MARROW TRANSPLANTATION, 2005, 35 (05) : 509 - 513
12345